Paper32100245
Synthesis, characterization, antimicrobial, antioxidant and computational evaluation of N-acyl-morpholine-4-carbothioamides.
Aziz H and 4 others. Mol Divers, 2021. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Synthesis, characterization, antimicrobial, antioxidant and computational evaluation of N-acyl-morpholine-4-carbothioamides. Papers, record 32100245. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32100245
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synthesis, characterization, antimicrobial, antioxidant and computational evaluation of N-acyl-morpholine-4-carbothioamides.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Antifungal Agents | Major topic |
| Antioxidants | Major topic |
| Morpholines | Major topic |
| Thioamides | Major topic |
| Aspergillus flavus | |
| Aspergillus niger | |
| Bacteria | |
| Biphenyl Compounds | |
| Cells, Cultured | |
| Erythrocytes | |
| Fusarium | |
| Hemolysis | |
| Humans | |
| Molecular Docking Simulation | |
| Picrates | |
| RNA |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Indigenous Scholarship | Higher Education Commision, Pakistan | PubMed |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14741262 | Synthesis and antifungal activities of phenylenedithioureas. | Bioorg Med Chem Lett | 2004 | https://conductscience.org/library/papers/14741262 | PubMed |
| 2 | 21481990 | Urea/thiourea derivatives of quinazolinone-lysine conjugates: synthesis and structure-activity relationships of a new series of antimicrobials. | Eur J Med Chem | 2011 | https://conductscience.org/library/papers/21481990 | PubMed |
| 3 | 22373815 | Co-ordination behaviour of a novel bisthiourea tripodal ligand: structural, spectroscopic and electrochemical properties of a series of transition metal complexes. | Dalton Trans | 2012 | https://conductscience.org/library/papers/22373815 | PubMed |
| 4 | 28774308 | Polarity directed optimization of phytochemical and in vitro biological potential of an indigenous folklore: Quercus dilatata Lindl. ex Royle. | BMC Complement Altern Med | 2017 | https://conductscience.org/library/papers/28774308 | PubMed |
| 5 | 16639718 | In vitro hemolysis: guidance for the pharmaceutical scientist. | J Pharm Sci | 2006 | https://conductscience.org/library/papers/16639718 | PubMed |
| 6 | 18083151 | Synthesis of acyl thiourea derivatives of chitosan and their antimicrobial activities in vitro. | Carbohydr Res | 2008 | https://conductscience.org/library/papers/18083151 | PubMed |
| 7 | 20162057 | In vitro antioxidant activities of the fractions of Coccinia grandis L. leaf extract. | Afr J Tradit Complement Altern Med | 2007 | https://conductscience.org/library/papers/20162057 | PubMed |
| 8 | 31375003 | Antibacterial Activity and Molecular Docking Studies of a Selected Series of Hydroxy-3-arylcoumarins. | Molecules | 2019 | https://conductscience.org/library/papers/31375003 | PubMed |
| 9 | 26165131 | SYNTHESIS AND IN VITRO ANTIMICROBIAL EVALUATION OF PIPERAZINE SUBSTITUTED QUINAZOLINE-BASED THIOUREA/THIAZOLIDINONE/CHALCONE HYBRIDS. | Bioorg Khim | 2015 | https://conductscience.org/library/papers/26165131 | PubMed |
| 10 | 12036371 | Molecular properties that influence the oral bioavailability of drug candidates. | J Med Chem | 2002 | https://conductscience.org/library/papers/12036371 | PubMed |
| 11 | 22554280 | Isolation of antibacterial compounds from Quercus dilatata L. through bioassay guided fractionation. | Ann Clin Microbiol Antimicrob | 2012 | https://conductscience.org/library/papers/22554280 | PubMed |
| 12 | 30872126 | Anti-tumor effects and 3D-quantitative structure-activity relationship analysis of bufadienolides from toad venom. | Fitoterapia | 2019 | https://conductscience.org/library/papers/30872126 | PubMed |
| 13 | 23524982 | Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs. | J Vis Exp | 2013 | https://conductscience.org/library/papers/23524982 | PubMed |
| 14 | 11731939 | Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. | Clin Infect Dis | 2002 | https://conductscience.org/library/papers/11731939 | PubMed |
| 15 | 23644194 | Thiourea derivatives incorporating a hippuric acid moiety: synthesis and evaluation of antibacterial and antifungal activities. | Eur J Med Chem | 2013 | https://conductscience.org/library/papers/23644194 | PubMed |
| 16 | 19231985 | Multidrug resistance in bacteria. | Annu Rev Biochem | 2009 | https://conductscience.org/library/papers/19231985 | PubMed |
| 17 | 11259830 | Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. | Adv Drug Deliv Rev | 2001 | https://conductscience.org/library/papers/11259830 | PubMed |
| 18 | 15388173 | Synthesis, antimicrobial activity and molecular modeling studies of halogenated 4-[1H-imidazol-1-yl(phenyl)methyl]-1,5-diphenyl-1H-pyrazoles. | Bioorg Med Chem | 2004 | https://conductscience.org/library/papers/15388173 | PubMed |
| 19 | 28041832 | Design, synthesis and antibacterial activities of thiouracil derivatives containing acyl thiourea as SecA inhibitors. | Bioorg Med Chem Lett | 2017 | https://conductscience.org/library/papers/28041832 | PubMed |
| 20 | 23441865 | 3D-QSAR and molecular docking for the discovery of ketolide derivatives. | Expert Opin Drug Discov | 2013 | https://conductscience.org/library/papers/23441865 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38790713 | In Vitro Antioxidant and In Silico Evaluation of the Anti-β-Lactamase Potential of the Extracts of Cylindrospermum alatosporum NR125682 and Loriellopsis cavenicola NR117881. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/38790713 | PubMed |
| 37375137 | In Vitro Anti-Microbial Activity and Anti-Cancer Potential of Novel Synthesized Carbamothioyl-Furan-2-Carboxamide Derivatives. | Molecules | 2023 | https://conductscience.org/library/papers/37375137 | PubMed |
| 35481107 | Novel adamantyl clubbed iminothiazolidinones as promising elastase inhibitors: design, synthesis, molecular docking, ADMET and DFT studies. | RSC Adv | 2022 | https://conductscience.org/library/papers/35481107 | PubMed |
| 34466093 | Exploring the therapeutic potential of Hibiscus rosa sinensis synthesized cobalt oxide (Co3O4-NPs) and magnesium oxide nanoparticles (MgO-NPs). | Saudi J Biol Sci | 2021 | https://conductscience.org/library/papers/34466093 | PubMed |
| 34238110 | Diaryl azo derivatives as anti-diabetic and antimicrobial agents: synthesis, in vitro, kinetic and docking studies. | J Enzyme Inhib Med Chem | 2021 | https://conductscience.org/library/papers/34238110 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32100245
GET https://conductscience.org/api/papers/v1/32100245/references?page=2